Antacids Global Market Report 2020
Report Highlights
Including: 1) Drug Class: Proton Pump Inhibitors, H2 Antagonist, Acid Neutralizers, Pro-Motility Agents 2) Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Others 3) By Formulation Type: Tablet, Liquid, Powder, Others
Covering: GlaxoSmithKline plc, Pfizer Inc., Bayer AG, Dr. Reddy's Laboratories Ltd, AstraZeneca PLC
Antacids Market Global Report 2020 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the global antacids market.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market research findings.
- Benchmark performance against key competitors.
- Utilize the relationships between key data sets for superior strategizing.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Description:
Where is the largest and fastest growing market for the antacids? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Antacids Market Global Report from The Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market.
- The Market Characteristics section of the report defines and explains the market.
- The Market Size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
- Market Segmentations break down market into sub markets.
- The Regional and Country section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.
- Competitive Landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The Trends and Strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.
Scope
Markets Covered: 1) Drug Class: Proton Pump Inhibitors, H2 Antagonist, Acid Neutralizers, Pro-Motility Agents 2) Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Others 3) By Formulation Type: Tablet, Liquid, Powder, Others
Companies Mentioned: GlaxoSmithKline plc, Pfizer Inc., Bayer AG, Dr. Reddy's Laboratories Ltd, AstraZeneca PLC
Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA
Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Time Series: Five years historic and forecast.
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Table 1 : Global Historic Market Growth, 2015-2019, $ Billion
- Table 2 : Global Forecast Market Growth, 2015-2022F, 2025F, 2030F, $ Billion
- Table 3 : Global Antacids Market, Segmentation Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
- Table 4 : Global Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
- Table 5 : Global Antacids Market, Segmentation By Formulation Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
- Table 6 : Global Antacids Market, Split By Region, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
- Table 7 : Global Antacids Market, Split By Country, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
- Table 8 : Asia-Pacific, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
- Table 9 : Asia-Pacific, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
- Table 10 : China, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
- Table 11 : China, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
- Table 12 : India, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
- Table 13 : India, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
- Table 14 : Japan, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
- Table 15 : Japan, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
- Table 16 : Australia, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
- Table 17 : Australia, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
- Table 18 : Indonesia, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
- Table 19 : Indonesia, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
- Table 20 : South Korea, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
- Table 21 : South Korea, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
- Table 22 : Western Europe, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
- Table 23 : Western Europe, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
- Table 24 : UK, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
- Table 25 : UK, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
- Table 26 : Germany, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
- Table 27 : Germany, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
- Table 28 : France, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
- Table 29 : France, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
- Table 30 : Eastern Europe, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
- Table 31 : Eastern Europe, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
- Table 32 : Russia, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
- Table 33 : Russia, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
- Table 34 : North America, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
- Table 35 : North America, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
- Table 36 : USA, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
- Table 37 : USA, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
- Table 38 : South America, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
- Table 39 : South America, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
- Table 40 : Brazil, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
- Table 41 : Brazil, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
- Table 42 : Middle East, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
- Table 43 : Middle East, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
- Table 44 : Africa, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
- Table 45 : Africa, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
- Table 46 : GlaxoSmithKline plc Financial Performance
- Table 47 : Pfizer Inc Financial Performance
- Table 48 : Bayer AG Financial Performance
- Table 49 : Dr. Reddy's Laboratories Ltd Financial Performance
- Table 50 : AstraZeneca PLC Financial Performance
- Figure 1 : Global Historic Market Growth, 2015-2019, $ Billion
- Figure 2 : Global Forecast Market Growth, 2015-2022F, 2025F, 2030F, $ Billion
- Figure 3 : Global Antacids Market, Segmentation Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
- Figure 4 : Global Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
- Figure 5 : Global Antacids Market, Segmentation By Formulation Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
- Figure 6 : Global Antacids Market, Split By Region, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
- Figure 7 : Global Antacids Market, Split By Country, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
- Figure 8 : Asia-Pacific, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
- Figure 9 : Asia-Pacific, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
- Figure 10 : China, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
- Figure 11 : China, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
- Figure 12 : India, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
- Figure 13 : India, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
- Figure 14 : Japan, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
- Figure 15 : Japan, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
- Figure 16 : Australia, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
- Figure 17 : Australia, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
- Figure 18 : Indonesia, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
- Figure 19 : Indonesia, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
- Figure 20 : South Korea, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
- Figure 21 : South Korea, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
- Figure 22 : Western Europe, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
- Figure 23 : Western Europe, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
- Figure 24 : UK, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
- Figure 25 : UK, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
- Figure 26 : Germany, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
- Figure 27 : Germany, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
- Figure 28 : France, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
- Figure 29 : France, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
- Figure 30 : Eastern Europe, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
- Figure 31 : Eastern Europe, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
- Figure 32 : Russia, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
- Figure 33 : Russia, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
- Figure 34 : North America, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
- Figure 35 : North America, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
- Figure 36 : USA, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
- Figure 37 : USA, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
- Figure 38 : South America, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
- Figure 39 : South America, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
- Figure 40 : Brazil, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
- Figure 41 : Brazil, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
- Figure 42 : Middle East, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
- Figure 43 : Middle East, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
- Figure 44 : Africa, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
- Figure 45 : Africa, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
- Figure 46 : GlaxoSmithKline plc Financial Performance
- Figure 47 : Pfizer Inc Financial Performance
- Figure 48 : Bayer AG Financial Performance
- Figure 49 : Dr. Reddy's Laboratories Ltd Financial Performance
- Figure 50 : AstraZeneca PLC Financial Performance
The Business Research Company is a market research and intelligence company which excels in company, market and consumer research. It has over 50 research professionals at its offices in India, the UK and the US as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.